Testing effectiveness (Phase 2)Looking for participantsNCT06499896
What this trial is testing
Healthy-donor Microbiome MTP-101-C in Steroid Relapse/Refractory Immune-related Cutaneous Adverse Events (irCAEs) and Immune-mediated Colitis (IMC)
Who this might be right for
Immune-mediated Colitis (IMC)Immune-related Dermatitis
Diwakar Davar 30